Načítá se...
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer immunity, which may result in immune checkpoint...
Uloženo v:
| Vydáno v: | Signal Transduct Target Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896069/ https://ncbi.nlm.nih.gov/pubmed/33608497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-00449-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|